Shares of Dynatronics (DYNT) has surged 67% following news that the company has renewed a distribution agreement with distributing partner Intalere.
The Bird & Cronin unit has been an Intalere preferred provider for more than 20 years. The latest extension takes that relationship through January 2024. With the ramping up of Covid-19 vaccines, that slowdown in elective procedures could be showing signs of a reversal, bringing with it an increased need for rehab products like those made by Dynatronics.
Dynatronics is a medical device company working on a wide range of restorative products. This includes those for use in rehabilitation, pain management, training, and more. Because its products are so broad in how they can be used, the company supplies a large range of different customers.
This includes clinics, hospitals, athletic trainers, and straight to consumers. In its pipeline are brands such as Bird & Cronin, Dynatron Solaris, Hausmann, and more. These brands are all categorized under the broader Dynatronics name. On February 24th, Dynatronics made a huge announcement with Intalere, sparking an over 65% after-hours gain.